2008
DOI: 10.1016/j.ijid.2007.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Detection of hepatitis G virus envelope protein E2 antibody in blood donors

Abstract: A low frequency of HGV exposure in blood donors was found in this study. We did not observe co-infection of HGV with HCV in our subjects, supporting the theory that although the parenteral route is the most effective means of transmission, other routes such as sexual contact and intra-familial contact may also play a role in HGV transmission.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
16
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(17 citation statements)
references
References 46 publications
1
16
0
Order By: Relevance
“…In Iranian volunteer blood donors the prevalence of GBV-C was around 1% [46]. A study of prevalence of GBV-C among northeastern Thai blood donors carrying HBsAg and anti-HCV revealed a higher frequency of GBV-C RNA (10% and 11%, respectively) in the co-infected when compared with the controls [47].…”
Section: Discussionmentioning
confidence: 99%
“…In Iranian volunteer blood donors the prevalence of GBV-C was around 1% [46]. A study of prevalence of GBV-C among northeastern Thai blood donors carrying HBsAg and anti-HCV revealed a higher frequency of GBV-C RNA (10% and 11%, respectively) in the co-infected when compared with the controls [47].…”
Section: Discussionmentioning
confidence: 99%
“…In an Amerindian population from Venezuela a high prevalence of GBV-C genotype 3 was observed, ranging from 5% (9 out of 162) in the West to 25% (14 out of 56) in the South region of the country [45]. The prevalence of GBV-C was 9.7% among 545 blood donors in Sao Paulo, Brazil [47], 8.3% in 1,039 healthy individuals, also from São Paulo, Brazil [48] or 1% from 478 Iranian volunteer blood donors [49].…”
Section: Introductionmentioning
confidence: 94%
“…Anti-E2 antibody can be distinguished in the beginning of infection and also later, along with HGV RNA, suggesting a window period between clearance of RNA and reappearance of anti-E2 antibody (14). There is an enzyme-linked immunosorbent assay (ELISA) test for the detection of anti-E2 antibody and a reverse transcription polymerase chain reaction (RT-PCR) test for the detection of RNA to diagnose HGV infection (15,16). The aim of this study was to epidemiologically survey prevalence and genotype distribution of HGV in patients with hepatitis B and C in the southwest of Iran.…”
Section: Introductionmentioning
confidence: 99%